• Naturally Occurring Enzyme Improves ALS Symptoms in Mice, Study Shows
  • Ethical Factors Should Be at Core of Radicava Treatment Discussions, Researchers Argue
  • University of Michigan Develops New Model for Predicting ALS Patients’ Survival
  • Time Matters
  • Easing the Nerve Cell Traffic Jam May Be a Way to Treat ALS, Research Suggests
  • Protein Called NAIP Seen as Potential ALS Disease Marker, Study Finds
  • Bioequivalence Study of Sublingual BHV-0223 Shows Positive Results as Rilutek Substitute
  • Canada’s NeuroSGC Partnership Seeks Potential Treatments for ALS, Parkinson’s Disease
  • American CryoStem’s Atcell Not Approved for ALS, Other Neurodegenerative Diseases, FDA Warns
  • How to Revive Your Daily Life Routines
  • Canadian Clinical Trial Recruiting ALS Patients to Test Antipsychotic Therapy Orap
  • Sangamo and Pfizer to Collaborate on Developing Gene Therapies for ALS